PT2200622E - Células aderentes provenientes de tecido adiposo ou placentário e respetiva utilização terapêutica - Google Patents

Info

Publication number

PT2200622E

PT2200622E PT08789856T PT08789856T PT2200622E PT 2200622 E PT2200622 E PT 2200622E PT 08789856 T PT08789856 T PT 08789856T PT 08789856 T PT08789856 T PT 08789856T PT 2200622 E PT2200622 E PT 2200622E

Authority

PT

Portugal

Prior art keywords

cells

adherent

culture

cell

protein

Prior art date

2007-09-19

Links

• Espacenet
• Global Dossier
• Discuss

• 230000001464 adherent effect Effects 0.000 title claims abstract description 161
• 210000000577 adipose tissue Anatomy 0.000 title abstract description 44
• 210000005059 placental tissue Anatomy 0.000 title description 29
• 238000002560 therapeutic procedure Methods 0.000 title description 2
• 208000028867 ischemia Diseases 0.000 claims abstract description 30
• 210000002808 connective tissue Anatomy 0.000 claims abstract description 29
• 230000017423 tissue regeneration Effects 0.000 claims abstract 3
• 210000004027 cell Anatomy 0.000 claims description 663
• 230000014509 gene expression Effects 0.000 claims description 94
• 238000011282 treatment Methods 0.000 claims description 73
• 238000004519 manufacturing process Methods 0.000 claims description 39
• 230000008439 repair process Effects 0.000 claims description 34
• 210000000130 stem cell Anatomy 0.000 claims description 32
• 230000003169 placental effect Effects 0.000 claims description 25
• 239000001963 growth medium Substances 0.000 claims description 22
• 239000000463 material Substances 0.000 claims description 22
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 20
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 20
• 230000008929 regeneration Effects 0.000 claims description 19
• 238000011069 regeneration method Methods 0.000 claims description 19
• 239000003550 marker Substances 0.000 claims description 18
• 208000005764 Peripheral Arterial Disease Diseases 0.000 claims description 17
• 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims description 17
• 238000012258 culturing Methods 0.000 claims description 11
• -1 polypropylene Polymers 0.000 claims description 11
• 230000010412 perfusion Effects 0.000 claims description 10
• 102100022464 5'-nucleotidase Human genes 0.000 claims description 9
• 102100037241 Endoglin Human genes 0.000 claims description 9
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 9
• 101000881679 Homo sapiens Endoglin Proteins 0.000 claims description 9
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 9
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 9
• 102100025304 Integrin beta-1 Human genes 0.000 claims description 9
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 9
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 8
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 8
• 239000008103 glucose Substances 0.000 claims description 8
• 239000005022 packaging material Substances 0.000 claims description 8
• 230000008105 immune reaction Effects 0.000 claims description 6
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 5
• 102000006354 HLA-DR Antigens Human genes 0.000 claims description 5
• 108010058597 HLA-DR Antigens Proteins 0.000 claims description 5
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 5
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 5
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 5
• 239000004743 Polypropylene Substances 0.000 claims description 5
• 229920000728 polyester Polymers 0.000 claims description 5
• 229920001155 polypropylene Polymers 0.000 claims description 5
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 4
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 4
• 210000003169 central nervous system Anatomy 0.000 claims description 4
• 238000001802 infusion Methods 0.000 claims description 4
• 230000000644 propagated effect Effects 0.000 claims description 3
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 2
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 2
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 2
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 2
• 230000035752 proliferative phase Effects 0.000 claims description 2
• 238000000034 method Methods 0.000 abstract description 66
• 210000001519 tissue Anatomy 0.000 abstract description 63
• 210000002826 placenta Anatomy 0.000 abstract description 59
• 108090000623 proteins and genes Proteins 0.000 description 120
• 102000004169 proteins and genes Human genes 0.000 description 71
• 241000699670 Mus sp. Species 0.000 description 68
• 235000018102 proteins Nutrition 0.000 description 68
• 239000002609 medium Substances 0.000 description 56
• 230000008859 change Effects 0.000 description 49
• 241001465754 Metazoa Species 0.000 description 42
• 241000282414 Homo sapiens Species 0.000 description 33
• 210000003414 extremity Anatomy 0.000 description 27
• 230000001965 increasing effect Effects 0.000 description 26
• 210000000988 bone and bone Anatomy 0.000 description 24
• 239000000969 carrier Substances 0.000 description 24
• 230000003993 interaction Effects 0.000 description 24
• 230000000302 ischemic effect Effects 0.000 description 24
• 238000004458 analytical method Methods 0.000 description 23
• 230000017531 blood circulation Effects 0.000 description 23
• 210000001185 bone marrow Anatomy 0.000 description 23
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
• 230000010261 cell growth Effects 0.000 description 21
• 201000010099 disease Diseases 0.000 description 21
• 230000006872 improvement Effects 0.000 description 21
• 239000000203 mixture Substances 0.000 description 21
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
• 230000012010 growth Effects 0.000 description 20
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 239000007924 injection Substances 0.000 description 19
• 238000002347 injection Methods 0.000 description 19
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 18
• 230000007547 defect Effects 0.000 description 18
• 108090000765 processed proteins & peptides Proteins 0.000 description 18
• 238000002054 transplantation Methods 0.000 description 18
• 230000001363 autoimmune Effects 0.000 description 17
• 210000000349 chromosome Anatomy 0.000 description 17
• 230000000694 effects Effects 0.000 description 17
• 229940090044 injection Drugs 0.000 description 17
• 210000004379 membrane Anatomy 0.000 description 17
• 239000012528 membrane Substances 0.000 description 17
• 208000006011 Stroke Diseases 0.000 description 16
• 238000002474 experimental method Methods 0.000 description 16
• 230000004044 response Effects 0.000 description 16
• 238000012360 testing method Methods 0.000 description 16
• 210000005259 peripheral blood Anatomy 0.000 description 15
• 239000011886 peripheral blood Substances 0.000 description 15
• 230000008569 process Effects 0.000 description 15
• 102000004196 processed proteins & peptides Human genes 0.000 description 15
• 230000035755 proliferation Effects 0.000 description 15
• 108700026244 Open Reading Frames Proteins 0.000 description 14
• 230000027455 binding Effects 0.000 description 14
• 239000000872 buffer Substances 0.000 description 14
• 210000000845 cartilage Anatomy 0.000 description 14
• 230000004069 differentiation Effects 0.000 description 14
• 210000004492 nuclear pore Anatomy 0.000 description 14
• 210000002435 tendon Anatomy 0.000 description 14
• 208000027418 Wounds and injury Diseases 0.000 description 13
• 238000004113 cell culture Methods 0.000 description 13
• 230000006870 function Effects 0.000 description 13
• 230000001976 improved effect Effects 0.000 description 13
• 238000012423 maintenance Methods 0.000 description 13
• 238000012544 monitoring process Methods 0.000 description 13
• 102000005962 receptors Human genes 0.000 description 13
• 108020003175 receptors Proteins 0.000 description 13
• 102000004127 Cytokines Human genes 0.000 description 12
• 108090000695 Cytokines Proteins 0.000 description 12
• 108060001084 Luciferase Proteins 0.000 description 12
• 230000003511 endothelial effect Effects 0.000 description 12
• 238000011156 evaluation Methods 0.000 description 12
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 12
• 239000008194 pharmaceutical composition Substances 0.000 description 12
• 229920001184 polypeptide Polymers 0.000 description 12
• 238000009331 sowing Methods 0.000 description 12
• 108091000080 Phosphotransferase Proteins 0.000 description 11
• 206010052428 Wound Diseases 0.000 description 11
• 210000002683 foot Anatomy 0.000 description 11
• 230000028993 immune response Effects 0.000 description 11
• 210000003041 ligament Anatomy 0.000 description 11
• 201000002818 limb ischemia Diseases 0.000 description 11
• 210000005087 mononuclear cell Anatomy 0.000 description 11
• 102000020233 phosphotransferase Human genes 0.000 description 11
• 230000009467 reduction Effects 0.000 description 11
• 230000002829 reductive effect Effects 0.000 description 11
• 239000000523 sample Substances 0.000 description 11
• 230000028327 secretion Effects 0.000 description 11
• 102000014914 Carrier Proteins Human genes 0.000 description 10
• 239000005089 Luciferase Substances 0.000 description 10
• 102100038169 Musculin Human genes 0.000 description 10
• 230000033115 angiogenesis Effects 0.000 description 10
• 108091008324 binding proteins Proteins 0.000 description 10
• 210000003995 blood forming stem cell Anatomy 0.000 description 10
• 230000006378 damage Effects 0.000 description 10
• 239000003814 drug Substances 0.000 description 10
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 10
• 238000003306 harvesting Methods 0.000 description 10
• 238000001727 in vivo Methods 0.000 description 10
• 210000003141 lower extremity Anatomy 0.000 description 10
• 238000010186 staining Methods 0.000 description 10
• 208000011580 syndromic disease Diseases 0.000 description 10
• 230000001225 therapeutic effect Effects 0.000 description 10
• 208000023275 Autoimmune disease Diseases 0.000 description 9
• 206010061216 Infarction Diseases 0.000 description 9
• 241000699666 Mus <mouse, genus> Species 0.000 description 9
• 206010028851 Necrosis Diseases 0.000 description 9
• 108020003224 Small Nucleolar RNA Proteins 0.000 description 9
• 102000042773 Small Nucleolar RNA Human genes 0.000 description 9
• 238000011161 development Methods 0.000 description 9
• 230000018109 developmental process Effects 0.000 description 9
• 239000012091 fetal bovine serum Substances 0.000 description 9
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 9
• 238000000338 in vitro Methods 0.000 description 9
• 230000007574 infarction Effects 0.000 description 9
• 230000017074 necrotic cell death Effects 0.000 description 9
• 230000003612 virological effect Effects 0.000 description 9
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 8
• 108010063296 Kinesin Proteins 0.000 description 8
• 102000010638 Kinesin Human genes 0.000 description 8
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
• 210000004700 fetal blood Anatomy 0.000 description 8
• 238000000684 flow cytometry Methods 0.000 description 8
• 239000007789 gas Substances 0.000 description 8
• 230000003394 haemopoietic effect Effects 0.000 description 8
• 238000002513 implantation Methods 0.000 description 8
• 239000011159 matrix material Substances 0.000 description 8
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 8
• 102000004190 Enzymes Human genes 0.000 description 7
• 108090000790 Enzymes Proteins 0.000 description 7
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
• 238000011789 NOD SCID mouse Methods 0.000 description 7
• 108700020796 Oncogene Proteins 0.000 description 7
• 239000004698 Polyethylene Substances 0.000 description 7
• 238000010171 animal model Methods 0.000 description 7
• 239000012298 atmosphere Substances 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 230000022131 cell cycle Effects 0.000 description 7
• 230000001413 cellular effect Effects 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• 239000003636 conditioned culture medium Substances 0.000 description 7
• 238000005538 encapsulation Methods 0.000 description 7
• 229940088598 enzyme Drugs 0.000 description 7
• 230000035876 healing Effects 0.000 description 7
• 230000036542 oxidative stress Effects 0.000 description 7
• 239000001301 oxygen Substances 0.000 description 7
• 229910052760 oxygen Inorganic materials 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 238000011084 recovery Methods 0.000 description 7
• 210000002966 serum Anatomy 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 210000000689 upper leg Anatomy 0.000 description 7
• 239000003981 vehicle Substances 0.000 description 7
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 6
• 208000010392 Bone Fractures Diseases 0.000 description 6
• 206010005949 Bone cancer Diseases 0.000 description 6
• 208000018084 Bone neoplasm Diseases 0.000 description 6
• 108010078791 Carrier Proteins Proteins 0.000 description 6
• 108020004414 DNA Proteins 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 101100450032 Gallus gallus H2AZ2 gene Proteins 0.000 description 6
• 239000012981 Hank's balanced salt solution Substances 0.000 description 6
• 206010061218 Inflammation Diseases 0.000 description 6
• 241000204031 Mycoplasma Species 0.000 description 6
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 6
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 6
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
• 210000001744 T-lymphocyte Anatomy 0.000 description 6
• 239000004480 active ingredient Substances 0.000 description 6
• 230000000735 allogeneic effect Effects 0.000 description 6
• 239000000427 antigen Substances 0.000 description 6
• 108091007433 antigens Proteins 0.000 description 6
• 102000036639 antigens Human genes 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 239000006285 cell suspension Substances 0.000 description 6
• 230000001419 dependent effect Effects 0.000 description 6
• 206010012601 diabetes mellitus Diseases 0.000 description 6
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 6
• 210000005260 human cell Anatomy 0.000 description 6
• 230000001506 immunosuppresive effect Effects 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 238000007918 intramuscular administration Methods 0.000 description 6
• 238000002955 isolation Methods 0.000 description 6
• 230000003902 lesion Effects 0.000 description 6
• 210000004698 lymphocyte Anatomy 0.000 description 6
• 238000002595 magnetic resonance imaging Methods 0.000 description 6
• 238000005259 measurement Methods 0.000 description 6
• 239000003094 microcapsule Substances 0.000 description 6
• 238000010899 nucleation Methods 0.000 description 6
• 238000004806 packaging method and process Methods 0.000 description 6
• 239000002243 precursor Substances 0.000 description 6
• 230000002062 proliferating effect Effects 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 229940104230 thymidine Drugs 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 102100033620 Calponin-1 Human genes 0.000 description 5
• 108010035532 Collagen Proteins 0.000 description 5
• 102000008186 Collagen Human genes 0.000 description 5
• 108060005980 Collagenase Proteins 0.000 description 5
• 102000029816 Collagenase Human genes 0.000 description 5
• 102000018884 Golgi Matrix Proteins Human genes 0.000 description 5
• 108010052778 Golgi Matrix Proteins Proteins 0.000 description 5
• 108010033040 Histones Proteins 0.000 description 5
• 101001078082 Homo sapiens Reticulocalbin-3 Proteins 0.000 description 5
• 108010050904 Interferons Proteins 0.000 description 5
• 102000014150 Interferons Human genes 0.000 description 5
• 102000004889 Interleukin-6 Human genes 0.000 description 5
• 108090001005 Interleukin-6 Proteins 0.000 description 5
• 102000001708 Protein Isoforms Human genes 0.000 description 5
• 108010029485 Protein Isoforms Proteins 0.000 description 5
• 102000018779 Replication Protein C Human genes 0.000 description 5
• 108010027647 Replication Protein C Proteins 0.000 description 5
• 102100025343 Reticulocalbin-3 Human genes 0.000 description 5
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 239000011575 calcium Substances 0.000 description 5
• 238000002512 chemotherapy Methods 0.000 description 5
• 229920001436 collagen Polymers 0.000 description 5
• 229960002424 collagenase Drugs 0.000 description 5
• 238000005138 cryopreservation Methods 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 210000002950 fibroblast Anatomy 0.000 description 5
• 239000003102 growth factor Substances 0.000 description 5
• 230000006698 induction Effects 0.000 description 5
• 229940079322 interferon Drugs 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 229960000988 nystatin Drugs 0.000 description 5
• 230000002188 osteogenic effect Effects 0.000 description 5
• 201000008968 osteosarcoma Diseases 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• 108091006112 ATPases Proteins 0.000 description 4
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 4
• 201000006474 Brain Ischemia Diseases 0.000 description 4
• 102100032912 CD44 antigen Human genes 0.000 description 4
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 4
• 229930182816 L-glutamine Natural products 0.000 description 4
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 241000204003 Mycoplasmatales Species 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 241000283977 Oryctolagus Species 0.000 description 4
• 108010047620 Phytohemagglutinins Proteins 0.000 description 4
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 4
• 230000006052 T cell proliferation Effects 0.000 description 4
• 108010022394 Threonine synthase Proteins 0.000 description 4
• 102000036693 Thrombopoietin Human genes 0.000 description 4
• 108010041111 Thrombopoietin Proteins 0.000 description 4
• 206010052779 Transplant rejections Diseases 0.000 description 4
• 102000044159 Ubiquitin Human genes 0.000 description 4
• 108090000848 Ubiquitin Proteins 0.000 description 4
• 239000003242 anti bacterial agent Substances 0.000 description 4
• 229940088710 antibiotic agent Drugs 0.000 description 4
• 230000005784 autoimmunity Effects 0.000 description 4
• 229910052791 calcium Inorganic materials 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 208000029078 coronary artery disease Diseases 0.000 description 4
• 210000004748 cultured cell Anatomy 0.000 description 4
• 230000003247 decreasing effect Effects 0.000 description 4
• 238000009826 distribution Methods 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 210000002889 endothelial cell Anatomy 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 239000004744 fabric Substances 0.000 description 4
• 230000036541 health Effects 0.000 description 4
• 230000004054 inflammatory process Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 206010025135 lupus erythematosus Diseases 0.000 description 4
• 238000004949 mass spectrometry Methods 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 208000031225 myocardial ischemia Diseases 0.000 description 4
• 230000000926 neurological effect Effects 0.000 description 4
• 210000002569 neuron Anatomy 0.000 description 4
• 229910052757 nitrogen Inorganic materials 0.000 description 4
• 235000015097 nutrients Nutrition 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 230000000399 orthopedic effect Effects 0.000 description 4
• 230000001582 osteoblastic effect Effects 0.000 description 4
• 230000007170 pathology Effects 0.000 description 4
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
• 239000000546 pharmaceutical excipient Substances 0.000 description 4
• 230000001885 phytohemagglutinin Effects 0.000 description 4
• 238000003908 quality control method Methods 0.000 description 4
• 239000011734 sodium Substances 0.000 description 4
• 238000003860 storage Methods 0.000 description 4
• 238000001356 surgical procedure Methods 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 230000014616 translation Effects 0.000 description 4
• 210000003954 umbilical cord Anatomy 0.000 description 4
• 201000001320 Atherosclerosis Diseases 0.000 description 3
• 241000271566 Aves Species 0.000 description 3
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
• 208000017234 Bone cyst Diseases 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 101150013553 CD40 gene Proteins 0.000 description 3
• 102100027217 CD82 antigen Human genes 0.000 description 3
• 101150047144 CDC28 gene Proteins 0.000 description 3
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
• 208000024172 Cardiovascular disease Diseases 0.000 description 3
• 206010008027 Cerebellar atrophy Diseases 0.000 description 3
• 206010008120 Cerebral ischaemia Diseases 0.000 description 3
• 206010053138 Congenital aplastic anaemia Diseases 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• 241000283086 Equidae Species 0.000 description 3
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
• 201000004939 Fanconi anemia Diseases 0.000 description 3
• 102100037362 Fibronectin Human genes 0.000 description 3
• 108091006027 G proteins Proteins 0.000 description 3
• 101100220044 Homo sapiens CD34 gene Proteins 0.000 description 3
• 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 3
• 101000945318 Homo sapiens Calponin-1 Proteins 0.000 description 3
• 101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 description 3
• 101000999079 Homo sapiens Radiation-inducible immediate-early gene IEX-1 Proteins 0.000 description 3
• 206010020772 Hypertension Diseases 0.000 description 3
• 102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 3
• 208000012902 Nervous system disease Diseases 0.000 description 3
• 208000025966 Neurological disease Diseases 0.000 description 3
• 241000906034 Orthops Species 0.000 description 3
• 241000366596 Osiris Species 0.000 description 3
• 206010031243 Osteogenesis imperfecta Diseases 0.000 description 3
• 206010034576 Peripheral ischaemia Diseases 0.000 description 3
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 102000001253 Protein Kinase Human genes 0.000 description 3
• 102000009572 RNA Polymerase II Human genes 0.000 description 3
• 108010009460 RNA Polymerase II Proteins 0.000 description 3
• 239000012980 RPMI-1640 medium Substances 0.000 description 3
• 102100036900 Radiation-inducible immediate-early gene IEX-1 Human genes 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• 102000004389 Ribonucleoproteins Human genes 0.000 description 3
• 108010081734 Ribonucleoproteins Proteins 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 102000006467 TATA-Box Binding Protein Human genes 0.000 description 3
• 108010044281 TATA-Box Binding Protein Proteins 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 3
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 239000000853 adhesive Substances 0.000 description 3
• 230000001070 adhesive effect Effects 0.000 description 3
• 210000001789 adipocyte Anatomy 0.000 description 3
• 210000004504 adult stem cell Anatomy 0.000 description 3
• 238000013019 agitation Methods 0.000 description 3
• 235000001014 amino acid Nutrition 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 229910002091 carbon monoxide Inorganic materials 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 210000002230 centromere Anatomy 0.000 description 3
• 206010008118 cerebral infarction Diseases 0.000 description 3
• 230000004087 circulation Effects 0.000 description 3
• 238000003501 co-culture Methods 0.000 description 3
• 230000000139 costimulatory effect Effects 0.000 description 3
• 230000034994 death Effects 0.000 description 3
• 231100000517 death Toxicity 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 230000003111 delayed effect Effects 0.000 description 3
• 238000001514 detection method Methods 0.000 description 3
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
• 229960003957 dexamethasone Drugs 0.000 description 3
• 102000004419 dihydrofolate reductase Human genes 0.000 description 3
• 230000009977 dual effect Effects 0.000 description 3
• 239000002158 endotoxin Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 210000003743 erythrocyte Anatomy 0.000 description 3
• 210000002744 extracellular matrix Anatomy 0.000 description 3
• 230000001605 fetal effect Effects 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 239000003365 glass fiber Substances 0.000 description 3
• 210000002216 heart Anatomy 0.000 description 3
• 230000002519 immonomodulatory effect Effects 0.000 description 3
• 230000005847 immunogenicity Effects 0.000 description 3
• 230000002055 immunohistochemical effect Effects 0.000 description 3
• 238000010348 incorporation Methods 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 102000006495 integrins Human genes 0.000 description 3
• 108010044426 integrins Proteins 0.000 description 3
• 239000007927 intramuscular injection Substances 0.000 description 3
• 208000023589 ischemic disease Diseases 0.000 description 3
• 210000002415 kinetochore Anatomy 0.000 description 3
• 229920006008 lipopolysaccharide Polymers 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 238000010369 molecular cloning Methods 0.000 description 3
• 230000000877 morphologic effect Effects 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 201000001119 neuropathy Diseases 0.000 description 3
• 230000007823 neuropathy Effects 0.000 description 3
• 230000011164 ossification Effects 0.000 description 3
• 201000008482 osteoarthritis Diseases 0.000 description 3
• 230000002572 peristaltic effect Effects 0.000 description 3
• 229920001432 poly(L-lactide) Polymers 0.000 description 3
• 108060006633 protein kinase Proteins 0.000 description 3
• 238000005070 sampling Methods 0.000 description 3
• 210000002460 smooth muscle Anatomy 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 210000002536 stromal cell Anatomy 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 230000008093 supporting effect Effects 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 230000009885 systemic effect Effects 0.000 description 3
• 210000003371 toe Anatomy 0.000 description 3
• 238000001890 transfection Methods 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• 208000019553 vascular disease Diseases 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• 239000002699 waste material Substances 0.000 description 3
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
• IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 2
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
• 102100036630 60S ribosomal protein L7a Human genes 0.000 description 2
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 2
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
• ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
• VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
• 208000024827 Alzheimer disease Diseases 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• 206010002091 Anaesthesia Diseases 0.000 description 2
• PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 2
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 2
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 101710092112 Calponin-1 Proteins 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 206010008096 Cerebral atrophy Diseases 0.000 description 2
• 206010061762 Chondropathy Diseases 0.000 description 2
• 208000032064 Chronic Limb-Threatening Ischemia Diseases 0.000 description 2
• 102100024338 Collagen alpha-3(VI) chain Human genes 0.000 description 2
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 229930105110 Cyclosporin A Natural products 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• 101710088194 Dehydrogenase Proteins 0.000 description 2
• 108010069091 Dystrophin Proteins 0.000 description 2
• 102000001039 Dystrophin Human genes 0.000 description 2
• 239000006145 Eagle's minimal essential medium Substances 0.000 description 2
• 102000016942 Elastin Human genes 0.000 description 2
• 108010014258 Elastin Proteins 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 101800003838 Epidermal growth factor Proteins 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 102000004315 Forkhead Transcription Factors Human genes 0.000 description 2
• 108090000852 Forkhead Transcription Factors Proteins 0.000 description 2
• 102100029115 Fumarylacetoacetase Human genes 0.000 description 2
• 102000030782 GTP binding Human genes 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 208000018522 Gastrointestinal disease Diseases 0.000 description 2
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 2
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 2
• 102100023903 Glycerol kinase Human genes 0.000 description 2
• 108700016170 Glycerol kinases Proteins 0.000 description 2
• 208000015023 Graves' disease Diseases 0.000 description 2
• 108010009202 Growth Factor Receptors Proteins 0.000 description 2
• 102000009465 Growth Factor Receptors Human genes 0.000 description 2
• 102100030690 Histone H2B type 1-C/E/F/G/I Human genes 0.000 description 2
• 102100034535 Histone H3.1 Human genes 0.000 description 2
• 102100034523 Histone H4 Human genes 0.000 description 2
• 101000853243 Homo sapiens 60S ribosomal protein L7a Proteins 0.000 description 2
• 101000909506 Homo sapiens Collagen alpha-3(VI) chain Proteins 0.000 description 2
• 101001084682 Homo sapiens Histone H2B type 1-C/E/F/G/I Proteins 0.000 description 2
• 101001067880 Homo sapiens Histone H4 Proteins 0.000 description 2
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
• 101000715157 Homo sapiens Transcription initiation factor TFIID subunit 9B Proteins 0.000 description 2
• WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
• 206010062016 Immunosuppression Diseases 0.000 description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 102100023915 Insulin Human genes 0.000 description 2
• 102100022338 Integrin alpha-M Human genes 0.000 description 2
• 102100022337 Integrin alpha-V Human genes 0.000 description 2
• 206010061246 Intervertebral disc degeneration Diseases 0.000 description 2
• 208000032382 Ischaemic stroke Diseases 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
• 230000027311 M phase Effects 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 206010027452 Metastases to bone Diseases 0.000 description 2
• 201000002481 Myositis Diseases 0.000 description 2
• 206010028665 Myxoedema Diseases 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 108010054076 Oncogene Proteins v-myb Proteins 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 208000001132 Osteoporosis Diseases 0.000 description 2
• 108010058846 Ovalbumin Proteins 0.000 description 2
• 102000004316 Oxidoreductases Human genes 0.000 description 2
• 108090000854 Oxidoreductases Proteins 0.000 description 2
• 201000011152 Pemphigus Diseases 0.000 description 2
• 229940122344 Peptidase inhibitor Drugs 0.000 description 2
• 108010044843 Peptide Initiation Factors Proteins 0.000 description 2
• 102000005877 Peptide Initiation Factors Human genes 0.000 description 2
• 102100030264 Pleckstrin Human genes 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 108010041388 Ribonucleotide Reductases Proteins 0.000 description 2
• 102000000505 Ribonucleotide Reductases Human genes 0.000 description 2
• 108010000605 Ribosomal Proteins Proteins 0.000 description 2
• 102000002278 Ribosomal Proteins Human genes 0.000 description 2
• 230000018199 S phase Effects 0.000 description 2
• 102000008847 Serpin Human genes 0.000 description 2
• 108050000761 Serpin Proteins 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 102000007000 Tenascin Human genes 0.000 description 2
• 108010008125 Tenascin Proteins 0.000 description 2
• 108060008245 Thrombospondin Proteins 0.000 description 2
• 102000002938 Thrombospondin Human genes 0.000 description 2
• 102100026637 Tight junction protein ZO-2 Human genes 0.000 description 2
• 101710120037 Toxin CcdB Proteins 0.000 description 2
• 102100033159 Transcription factor 19 Human genes 0.000 description 2
• 101710119700 Transcription factor 19 Proteins 0.000 description 2
• 102100036653 Transcription initiation factor TFIID subunit 9B Human genes 0.000 description 2
• 102000004243 Tubulin Human genes 0.000 description 2
• 108090000704 Tubulin Proteins 0.000 description 2
• 101710183681 Uncharacterized protein 7 Proteins 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 241000269370 Xenopus <genus> Species 0.000 description 2
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
• XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 229940072056 alginate Drugs 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 2
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 230000037005 anaesthesia Effects 0.000 description 2
• 230000003698 anagen phase Effects 0.000 description 2
• 238000000540 analysis of variance Methods 0.000 description 2
• 210000001264 anterior cruciate ligament Anatomy 0.000 description 2
• 230000000469 anti-sperm effect Effects 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 210000001188 articular cartilage Anatomy 0.000 description 2
• 238000009227 behaviour therapy Methods 0.000 description 2
• 230000003542 behavioural effect Effects 0.000 description 2
• 150000001556 benzimidazoles Chemical class 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 230000033558 biomineral tissue development Effects 0.000 description 2
• 239000003114 blood coagulation factor Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 230000010478 bone regeneration Effects 0.000 description 2
• 230000006931 brain damage Effects 0.000 description 2
• 231100000874 brain damage Toxicity 0.000 description 2
• 208000029028 brain injury Diseases 0.000 description 2
• 229960002092 busulfan Drugs 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 230000034303 cell budding Effects 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 239000002771 cell marker Substances 0.000 description 2
• 239000002791 cell membrane marker Substances 0.000 description 2
• 238000002659 cell therapy Methods 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000000919 ceramic Substances 0.000 description 2
• 230000002490 cerebral effect Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 229960001265 ciclosporin Drugs 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 230000000536 complexating effect Effects 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 108010057108 condensin complexes Proteins 0.000 description 2
• 208000018631 connective tissue disease Diseases 0.000 description 2
• 210000003785 decidua Anatomy 0.000 description 2
• 208000018180 degenerative disc disease Diseases 0.000 description 2
• 238000000432 density-gradient centrifugation Methods 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 238000009792 diffusion process Methods 0.000 description 2
• 108091007734 digestive enzymes Proteins 0.000 description 2
• 102000038379 digestive enzymes Human genes 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 231100000673 dose–response relationship Toxicity 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 229920002549 elastin Polymers 0.000 description 2
• 238000000635 electron micrograph Methods 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 229940116977 epidermal growth factor Drugs 0.000 description 2
• 210000001808 exosome Anatomy 0.000 description 2
• 210000001105 femoral artery Anatomy 0.000 description 2
• 108700014844 flt3 ligand Proteins 0.000 description 2
• 239000006260 foam Substances 0.000 description 2
• 239000012595 freezing medium Substances 0.000 description 2
• 108010022687 fumarylacetoacetase Proteins 0.000 description 2
• 238000003633 gene expression assay Methods 0.000 description 2
• 208000016361 genetic disease Diseases 0.000 description 2
• 230000000762 glandular Effects 0.000 description 2
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 2
• 230000004190 glucose uptake Effects 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 230000005484 gravity Effects 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 208000000509 infertility Diseases 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 231100000535 infertility Toxicity 0.000 description 2
• 230000008798 inflammatory stress Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 230000002608 insulinlike Effects 0.000 description 2
• 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 210000002414 leg Anatomy 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 238000007443 liposuction Methods 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 238000004020 luminiscence type Methods 0.000 description 2
• 201000005202 lung cancer Diseases 0.000 description 2
• 208000020816 lung neoplasm Diseases 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 230000008774 maternal effect Effects 0.000 description 2
• 230000010534 mechanism of action Effects 0.000 description 2
• 108020004999 messenger RNA Proteins 0.000 description 2
• 230000009401 metastasis Effects 0.000 description 2
• 238000002493 microarray Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000009456 molecular mechanism Effects 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 230000007659 motor function Effects 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 208000010125 myocardial infarction Diseases 0.000 description 2
• 208000003786 myxedema Diseases 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 230000001272 neurogenic effect Effects 0.000 description 2
• 238000010606 normalization Methods 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 210000000963 osteoblast Anatomy 0.000 description 2
• 229940092253 ovalbumin Drugs 0.000 description 2
• 230000002611 ovarian Effects 0.000 description 2
• 230000036407 pain Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 239000002504 physiological saline solution Substances 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 108010026735 platelet protein P47 Proteins 0.000 description 2
• 229920001296 polysiloxane Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 239000011148 porous material Substances 0.000 description 2
• 230000035935 pregnancy Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• 201000007094 prostatitis Diseases 0.000 description 2
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 2
• 238000000275 quality assurance Methods 0.000 description 2
• 238000011555 rabbit model Methods 0.000 description 2
• 238000011946 reduction process Methods 0.000 description 2
• 230000001172 regenerating effect Effects 0.000 description 2
• 238000007634 remodeling Methods 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 2
• 230000001953 sensory effect Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 239000003001 serine protease inhibitor Substances 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 208000017520 skin disease Diseases 0.000 description 2
• 230000002269 spontaneous effect Effects 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 238000009168 stem cell therapy Methods 0.000 description 2
• 238000009580 stem-cell therapy Methods 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 229920002994 synthetic fiber Polymers 0.000 description 2
• 229920001897 terpolymer Polymers 0.000 description 2
• 108060008226 thioredoxin Proteins 0.000 description 2
• 210000002303 tibia Anatomy 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 238000000207 volumetry Methods 0.000 description 2
• 230000029663 wound healing Effects 0.000 description 2
• 229910052725 zinc Inorganic materials 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
• GIANIJCPTPUNBA-QMMMGPOBSA-N (2s)-3-(4-hydroxyphenyl)-2-nitramidopropanoic acid Chemical compound [O-][N+](=O)N[C@H](C(=O)O)CC1=CC=C(O)C=C1 GIANIJCPTPUNBA-QMMMGPOBSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
• TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
• WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
• WCFAPJDPAPDDAQ-UHFFFAOYSA-N 1,2-dihydropyrimidine Chemical compound C1NC=CC=N1 WCFAPJDPAPDDAQ-UHFFFAOYSA-N 0.000 description 1
• GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
• RCWJMKCTHJPXJV-UHFFFAOYSA-N 2,5-bis(aziridin-1-yl)-1,4-benzoquinone Chemical compound O=C1C=C(N2CC2)C(=O)C=C1N1CC1 RCWJMKCTHJPXJV-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
• UBDXZYYYWGIRGN-UHFFFAOYSA-N 2-cyano-5-phenylpenta-2,4-dienoic acid Chemical compound OC(=O)C(C#N)=CC=CC1=CC=CC=C1 UBDXZYYYWGIRGN-UHFFFAOYSA-N 0.000 description 1
• 108091071337 20 family Proteins 0.000 description 1
• 102100029510 26S proteasome regulatory subunit 6A Human genes 0.000 description 1
• QYNUQALWYRSVHF-ABLWVSNPSA-N 5,10-methylenetetrahydrofolic acid Chemical compound C1N2C=3C(=O)NC(N)=NC=3NCC2CN1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-ABLWVSNPSA-N 0.000 description 1
• BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108050000246 AAA domains Proteins 0.000 description 1
• 108090000067 ADP-Ribosylation Factor 6 Proteins 0.000 description 1
• 102100039900 ADP-ribosylation factor 6 Human genes 0.000 description 1
• 101150092254 ASF1 gene Proteins 0.000 description 1
• 102100020969 ATP-binding cassette sub-family E member 1 Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010059616 Activins Proteins 0.000 description 1
• 102000005606 Activins Human genes 0.000 description 1
• 208000030090 Acute Disease Diseases 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 102100040152 Adenylyl-sulfate kinase Human genes 0.000 description 1
• 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102000052030 Aldehyde Dehydrogenase 1 Family Human genes 0.000 description 1
• 108700041701 Aldehyde Dehydrogenase 1 Family Proteins 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 102100040141 Aminopeptidase O Human genes 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 241000212977 Andira Species 0.000 description 1
• 102100034608 Angiopoietin-2 Human genes 0.000 description 1
• 108010048036 Angiopoietin-2 Proteins 0.000 description 1
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
• 102100034564 Ankyrin repeat domain-containing protein 36A Human genes 0.000 description 1
• 102000000412 Annexin Human genes 0.000 description 1
• 108050008874 Annexin Proteins 0.000 description 1
• 102100034613 Annexin A2 Human genes 0.000 description 1
• 108090000668 Annexin A2 Proteins 0.000 description 1
• 102000003787 Anoctamin-1 Human genes 0.000 description 1
• 108090000160 Anoctamin-1 Proteins 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 101710095342 Apolipoprotein B Proteins 0.000 description 1
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
• 101001078592 Arabidopsis thaliana 11-beta-hydroxysteroid dehydrogenase-like 2 Proteins 0.000 description 1
• 101100278885 Arabidopsis thaliana E2FE gene Proteins 0.000 description 1
• 101001026154 Arabidopsis thaliana Glutathione S-transferase U14 Proteins 0.000 description 1
• 200000000007 Arterial disease Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 208000008037 Arthrogryposis Diseases 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 102100032311 Aurora kinase A Human genes 0.000 description 1
• 206010071155 Autoimmune arthritis Diseases 0.000 description 1
• 208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 101150072950 BRCA1 gene Proteins 0.000 description 1
• 102000052609 BRCA2 Human genes 0.000 description 1
• 108700020462 BRCA2 Proteins 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 101710167543 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 description 1
• 102100039888 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Human genes 0.000 description 1
• 102000004954 Biglycan Human genes 0.000 description 1
• 108090001138 Biglycan Proteins 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 208000005692 Bloom Syndrome Diseases 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 102100027951 Brain and acute leukemia cytoplasmic protein Human genes 0.000 description 1
• 101710122598 Brain and acute leukemia cytoplasmic protein Proteins 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• 206010048962 Brain oedema Diseases 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 102000001805 Bromodomains Human genes 0.000 description 1
• 108050009021 Bromodomains Proteins 0.000 description 1
• 102000027791 CD44 antigen Human genes 0.000 description 1
• 108091016585 CD44 antigen Proteins 0.000 description 1
• 102300038161 CD44 antigen isoform 2 Human genes 0.000 description 1
• 101150103402 CDON gene Proteins 0.000 description 1
• 102100028879 COP9 signalosome complex subunit 8 Human genes 0.000 description 1
• 102100039866 CTP synthase 1 Human genes 0.000 description 1
• 108010018956 CTP synthetase Proteins 0.000 description 1
• 101100326430 Caenorhabditis elegans bub-1 gene Proteins 0.000 description 1
• 101100156752 Caenorhabditis elegans cwn-1 gene Proteins 0.000 description 1
• 101100277553 Caenorhabditis elegans dep-1 gene Proteins 0.000 description 1
• 108010028326 Calbindin 2 Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 102100021849 Calretinin Human genes 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 102000004031 Carboxy-Lyases Human genes 0.000 description 1
• 108090000489 Carboxy-Lyases Proteins 0.000 description 1
• 102100032378 Carboxypeptidase E Human genes 0.000 description 1
• 108010058255 Carboxypeptidase H Proteins 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
• 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
• 102100028003 Catenin alpha-1 Human genes 0.000 description 1
• 101710106619 Catenin alpha-3 Proteins 0.000 description 1
• 102000016362 Catenins Human genes 0.000 description 1
• 108010067316 Catenins Proteins 0.000 description 1
• 102000003902 Cathepsin C Human genes 0.000 description 1
• 108090000267 Cathepsin C Proteins 0.000 description 1
• 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
• 102100025053 Cell division control protein 45 homolog Human genes 0.000 description 1
• 102100037677 Cell surface hyaluronidase Human genes 0.000 description 1
• 101710125063 Cell surface hyaluronidase Proteins 0.000 description 1
• 102100031219 Centrosomal protein of 55 kDa Human genes 0.000 description 1
• 102000004201 Ceramidases Human genes 0.000 description 1
• 108090000751 Ceramidases Proteins 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010010786 Cholesterol 25-hydroxylase Proteins 0.000 description 1
• UDKCHVLMFQVBAA-UHFFFAOYSA-M Choline salicylate Chemical compound C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O UDKCHVLMFQVBAA-UHFFFAOYSA-M 0.000 description 1
• 108010009685 Cholinergic Receptors Proteins 0.000 description 1
• 206010008748 Chorea Diseases 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
• 102000003780 Clusterin Human genes 0.000 description 1
• 108090000197 Clusterin Proteins 0.000 description 1
• 208000015943 Coeliac disease Diseases 0.000 description 1
• 102100027440 Cofilin-2 Human genes 0.000 description 1
• 102000012422 Collagen Type I Human genes 0.000 description 1
• 108010022452 Collagen Type I Proteins 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 102000012432 Collagen Type V Human genes 0.000 description 1
• 108010022514 Collagen Type V Proteins 0.000 description 1
• 102000014870 Collagen Type XII Human genes 0.000 description 1
• 108010039001 Collagen Type XII Proteins 0.000 description 1
• 102100024335 Collagen alpha-1(VII) chain Human genes 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108010062580 Concanavalin A Proteins 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 102000016736 Cyclin Human genes 0.000 description 1
• 108050006400 Cyclin Proteins 0.000 description 1
• 108010060273 Cyclin A2 Proteins 0.000 description 1
• 108010060385 Cyclin B1 Proteins 0.000 description 1
• 108010060387 Cyclin B2 Proteins 0.000 description 1
• 102100025191 Cyclin-A2 Human genes 0.000 description 1
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
• 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
• 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 1
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
• 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
• 102000015833 Cystatin Human genes 0.000 description 1
• 102100032759 Cysteine-rich motor neuron 1 protein Human genes 0.000 description 1
• 102100026533 Cytochrome P450 1A2 Human genes 0.000 description 1
• VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 description 1
• 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 1
• 102100035185 DNA excision repair protein ERCC-6-like Human genes 0.000 description 1
• 102100033587 DNA topoisomerase 2-alpha Human genes 0.000 description 1
• 102100032883 DNA-binding protein SATB2 Human genes 0.000 description 1
• 102100027641 DNA-binding protein inhibitor ID-1 Human genes 0.000 description 1
• 101710152088 DNA-binding protein inhibitor ID-1 Proteins 0.000 description 1
• 101100109110 Danio rerio aph1b gene Proteins 0.000 description 1
• 102100031601 Dedicator of cytokinesis protein 11 Human genes 0.000 description 1
• 108020005199 Dehydrogenases Proteins 0.000 description 1
• 206010012559 Developmental delay Diseases 0.000 description 1
• 241000630627 Diodella Species 0.000 description 1
• 102100036109 Dual specificity protein kinase TTK Human genes 0.000 description 1
• 102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 1
• 102100031534 E3 ubiquitin-protein ligase RNF144A Human genes 0.000 description 1
• 102100039639 E3 ubiquitin-protein ligase pellino homolog 1 Human genes 0.000 description 1
• 101710150169 E3 ubiquitin-protein ligase pellino homolog 1 Proteins 0.000 description 1
• 102000012545 EGF-like domains Human genes 0.000 description 1
• 108050002150 EGF-like domains Proteins 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 238000008157 ELISA kit Methods 0.000 description 1
• 102100036437 Ectonucleoside triphosphate diphosphohydrolase 6 Human genes 0.000 description 1
• 101710116079 Ectonucleoside triphosphate diphosphohydrolase 6 Proteins 0.000 description 1
• 102100031334 Elongation factor 2 Human genes 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 101000600890 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) G2-specific protein kinase nimA Proteins 0.000 description 1
• 102100028773 Endonuclease 8-like 3 Human genes 0.000 description 1
• 101710150754 Endonuclease 8-like 3 Proteins 0.000 description 1
• 102100021597 Endoplasmic reticulum aminopeptidase 2 Human genes 0.000 description 1
• 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 108010008165 Etanercept Proteins 0.000 description 1
• 101710139370 Eukaryotic translation elongation factor 2 Proteins 0.000 description 1
• 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
• 102100029075 Exonuclease 1 Human genes 0.000 description 1
• 102100029091 Exportin-2 Human genes 0.000 description 1
• 102100021654 Extracellular sulfatase Sulf-2 Human genes 0.000 description 1
• 102100020903 Ezrin Human genes 0.000 description 1
• 102100040669 F-box only protein 32 Human genes 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• 102100024058 Flap endonuclease GEN homolog 1 Human genes 0.000 description 1
• 102100035068 Fructosamine-3-kinase Human genes 0.000 description 1
• 102000034286 G proteins Human genes 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 1
• 230000010337 G2 phase Effects 0.000 description 1
• 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
• 102100033201 G2/mitotic-specific cyclin-B2 Human genes 0.000 description 1
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
• 102000018898 GTPase-Activating Proteins Human genes 0.000 description 1
• 108091006094 GTPase-accelerating proteins Proteins 0.000 description 1
• 108091006109 GTPases Proteins 0.000 description 1
• 102100021023 Gamma-glutamyl hydrolase Human genes 0.000 description 1
• 206010017711 Gangrene Diseases 0.000 description 1
• 102100037391 Gasdermin-E Human genes 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108010026132 Gelatinases Proteins 0.000 description 1
• 102000013382 Gelatinases Human genes 0.000 description 1
• 108090000577 Geminin Proteins 0.000 description 1
• 102000004064 Geminin Human genes 0.000 description 1
• 208000031448 Genomic Instability Diseases 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 1
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
• 206010018378 Glomerulonephritis rapidly progressive Diseases 0.000 description 1
• WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• 102000004263 Glutamate-Cysteine Ligase Human genes 0.000 description 1
• 108010081687 Glutamate-cysteine ligase Proteins 0.000 description 1
• 108010063907 Glutathione Reductase Proteins 0.000 description 1
• 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
• 102100030395 Glycerol-3-phosphate dehydrogenase, mitochondrial Human genes 0.000 description 1
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 1
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
• 208000003807 Graves Disease Diseases 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
• 102100028893 Hemicentin-1 Human genes 0.000 description 1
• 101710142180 Hemicentin-1 Proteins 0.000 description 1
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
• 208000027761 Hepatic autoimmune disease Diseases 0.000 description 1
• 108010061414 Hepatocyte Nuclear Factor 1-beta Proteins 0.000 description 1
• 102100022123 Hepatocyte nuclear factor 1-beta Human genes 0.000 description 1
• 208000031953 Hereditary hemorrhagic telangiectasia Diseases 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 102100022128 High mobility group protein B2 Human genes 0.000 description 1
• 102000017286 Histone H2A Human genes 0.000 description 1
• 108050005231 Histone H2A Proteins 0.000 description 1
• 102100039849 Histone H2A type 1 Human genes 0.000 description 1
• 102100030650 Histone H2B type 1-H Human genes 0.000 description 1
• 101710160686 Histone H2B type 1-H Proteins 0.000 description 1
• 101710195388 Histone H3.1 Proteins 0.000 description 1
• 102100033636 Histone H3.2 Human genes 0.000 description 1
• 102000006947 Histones Human genes 0.000 description 1
• 101150067143 Hnrnph1 gene Proteins 0.000 description 1
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
• 102100039542 Homeobox protein Hox-A2 Human genes 0.000 description 1
• 102100021090 Homeobox protein Hox-A9 Human genes 0.000 description 1
• 102100034862 Homeobox protein Hox-B2 Human genes 0.000 description 1
• 102100028411 Homeobox protein Hox-B3 Human genes 0.000 description 1
• 102100025056 Homeobox protein Hox-B6 Human genes 0.000 description 1
• 101001125540 Homo sapiens 26S proteasome regulatory subunit 6A Proteins 0.000 description 1
• 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 description 1
• 101000783786 Homo sapiens ATP-binding cassette sub-family E member 1 Proteins 0.000 description 1
• 101000610212 Homo sapiens Adenylyl-sulfate kinase Proteins 0.000 description 1
• 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
• 101000889627 Homo sapiens Aminopeptidase O Proteins 0.000 description 1
• 101000924345 Homo sapiens Ankyrin repeat domain-containing protein 36B Proteins 0.000 description 1
• 101000916502 Homo sapiens COP9 signalosome complex subunit 8 Proteins 0.000 description 1
• 101000934421 Homo sapiens Cell division control protein 45 homolog Proteins 0.000 description 1
• 101000776447 Homo sapiens Centrosomal protein of 55 kDa Proteins 0.000 description 1
• 101000725605 Homo sapiens Cofilin-2 Proteins 0.000 description 1
• 101000909498 Homo sapiens Collagen alpha-1(VII) chain Proteins 0.000 description 1
• 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
• 101000942095 Homo sapiens Cysteine-rich motor neuron 1 protein Proteins 0.000 description 1
• 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 1
• 101000876524 Homo sapiens DNA excision repair protein ERCC-6-like Proteins 0.000 description 1
• 101000801505 Homo sapiens DNA topoisomerase 2-alpha Proteins 0.000 description 1
• 101000655236 Homo sapiens DNA-binding protein SATB2 Proteins 0.000 description 1
• 101000866270 Homo sapiens Dedicator of cytokinesis protein 11 Proteins 0.000 description 1
• 101000659223 Homo sapiens Dual specificity protein kinase TTK Proteins 0.000 description 1
• 101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 description 1
• 101001130401 Homo sapiens E3 ubiquitin-protein ligase RAD18 Proteins 0.000 description 1
• 101001130270 Homo sapiens E3 ubiquitin-protein ligase RNF144A Proteins 0.000 description 1
• 101000898718 Homo sapiens Endoplasmic reticulum aminopeptidase 2 Proteins 0.000 description 1
• 101000770958 Homo sapiens Exportin-2 Proteins 0.000 description 1
• 101000820626 Homo sapiens Extracellular sulfatase Sulf-2 Proteins 0.000 description 1
• 101000854648 Homo sapiens Ezrin Proteins 0.000 description 1
• 101000892323 Homo sapiens F-box only protein 32 Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101000833646 Homo sapiens Flap endonuclease GEN homolog 1 Proteins 0.000 description 1
• 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 1
• 101001026269 Homo sapiens Gasdermin-E Proteins 0.000 description 1
• 101001009678 Homo sapiens Glycerol-3-phosphate dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
• 101001045791 Homo sapiens High mobility group protein B2 Proteins 0.000 description 1
• 101001035431 Homo sapiens Histone H2A type 1 Proteins 0.000 description 1
• 101001067844 Homo sapiens Histone H3.1 Proteins 0.000 description 1
• 101000871895 Homo sapiens Histone H3.2 Proteins 0.000 description 1
• 101000962636 Homo sapiens Homeobox protein Hox-A2 Proteins 0.000 description 1
• 101001019752 Homo sapiens Homeobox protein Hox-B2 Proteins 0.000 description 1
• 101000839775 Homo sapiens Homeobox protein Hox-B3 Proteins 0.000 description 1
• 101001077542 Homo sapiens Homeobox protein Hox-B6 Proteins 0.000 description 1
• 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
• 101001054732 Homo sapiens Inhibin beta A chain Proteins 0.000 description 1
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
• 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
• 101000590482 Homo sapiens Kinetochore protein Nuf2 Proteins 0.000 description 1
• 101000701585 Homo sapiens Kinetochore protein Spc24 Proteins 0.000 description 1
• 101000711455 Homo sapiens Kinetochore protein Spc25 Proteins 0.000 description 1
• 101001018026 Homo sapiens Lysosomal alpha-glucosidase Proteins 0.000 description 1
• 101001011906 Homo sapiens Matrix metalloproteinase-14 Proteins 0.000 description 1
• 101001000302 Homo sapiens Max-interacting protein 1 Proteins 0.000 description 1
• 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 1
• 101000957259 Homo sapiens Mitotic spindle assembly checkpoint protein MAD2A Proteins 0.000 description 1
• 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
• 101000973615 Homo sapiens Nuclear envelope integral membrane protein 1 Proteins 0.000 description 1
• 101000603425 Homo sapiens Nuclear pore complex-interacting protein family member B3 Proteins 0.000 description 1
• 101000585555 Homo sapiens PCNA-associated factor Proteins 0.000 description 1
• 101000738243 Homo sapiens Patched domain-containing protein 4 Proteins 0.000 description 1
• 101001091191 Homo sapiens Peptidyl-prolyl cis-trans isomerase F, mitochondrial Proteins 0.000 description 1
• 101001074628 Homo sapiens Phosphatidylinositol-glycan biosynthesis class W protein Proteins 0.000 description 1
• 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 1
• 101000909879 Homo sapiens Protein cornichon homolog 3 Proteins 0.000 description 1
• 101000928406 Homo sapiens Protein diaphanous homolog 3 Proteins 0.000 description 1
• 101000831286 Homo sapiens Protein timeless homolog Proteins 0.000 description 1
• 101001072237 Homo sapiens Protocadherin-16 Proteins 0.000 description 1
• 101001048702 Homo sapiens RNA polymerase II elongation factor ELL2 Proteins 0.000 description 1
• 101000884234 Homo sapiens Renal cancer differentiation gene 1 protein Proteins 0.000 description 1
• 101000744331 Homo sapiens Retinoblastoma-like protein 1 Proteins 0.000 description 1
• 101000588545 Homo sapiens Serine/threonine-protein kinase Nek7 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000651893 Homo sapiens Slit homolog 3 protein Proteins 0.000 description 1
• 101000830894 Homo sapiens Targeting protein for Xklp2 Proteins 0.000 description 1
• 101000945477 Homo sapiens Thymidine kinase, cytosolic Proteins 0.000 description 1
• 101000713613 Homo sapiens Tubulin beta-4B chain Proteins 0.000 description 1
• 101000867811 Homo sapiens Voltage-dependent L-type calcium channel subunit alpha-1C Proteins 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 208000035150 Hypercholesterolemia Diseases 0.000 description 1
• 208000031226 Hyperlipidaemia Diseases 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102100035692 Importin subunit alpha-1 Human genes 0.000 description 1
• 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102100027004 Inhibin beta A chain Human genes 0.000 description 1
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
• 102100032818 Integrin alpha-4 Human genes 0.000 description 1
• 102000000510 Integrin alpha3 Human genes 0.000 description 1
• 108010041357 Integrin alpha3 Proteins 0.000 description 1
• 108010072255 Integrin alpha3beta1 Proteins 0.000 description 1
• 108010041012 Integrin alpha4 Proteins 0.000 description 1
• 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
• 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
• 102100039879 Interleukin-19 Human genes 0.000 description 1
• 108050009288 Interleukin-19 Proteins 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102100026019 Interleukin-6 Human genes 0.000 description 1
• 102100021592 Interleukin-7 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 208000026492 Isaac syndrome Diseases 0.000 description 1
• 208000000209 Isaacs syndrome Diseases 0.000 description 1
• 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
• 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
• 108090000769 Isomerases Proteins 0.000 description 1
• 102000004195 Isomerases Human genes 0.000 description 1
• UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
• 108010040149 Junctional Adhesion Molecule B Proteins 0.000 description 1
• 102100023430 Junctional adhesion molecule B Human genes 0.000 description 1
• 102100037153 Keratin, type I cytoskeletal 27 Human genes 0.000 description 1
• 101710183657 Keratin, type I cytoskeletal 27 Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102100032431 Kinetochore protein Nuf2 Human genes 0.000 description 1
• 102100030536 Kinetochore protein Spc24 Human genes 0.000 description 1
• JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 108010007622 LDL Lipoproteins Proteins 0.000 description 1
• 102000007330 LDL Lipoproteins Human genes 0.000 description 1
• 108010021101 Lamin Type B Proteins 0.000 description 1
• 102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 description 1
• 101710163560 Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 1
• 101710189385 Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 1
• 108010085895 Laminin Proteins 0.000 description 1
• 206010061223 Ligament injury Diseases 0.000 description 1
• 101710098556 Lipase A Proteins 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
• 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
• 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 1
• 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
• SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
• 102000003843 Metalloendopeptidases Human genes 0.000 description 1
• 108090000131 Metalloendopeptidases Proteins 0.000 description 1
• 102000005741 Metalloproteases Human genes 0.000 description 1
• 108010006035 Metalloproteases Proteins 0.000 description 1
• CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
• VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
• 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 1
• 102100038792 Mitotic spindle assembly checkpoint protein MAD2A Human genes 0.000 description 1
• 101100225689 Mus musculus Enah gene Proteins 0.000 description 1
• 208000029578 Muscle disease Diseases 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• 206010028372 Muscular weakness Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
• MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
• 102100023175 NADP-dependent malic enzyme Human genes 0.000 description 1
• 108010018525 NFATC Transcription Factors Proteins 0.000 description 1
• 102000002673 NFATC Transcription Factors Human genes 0.000 description 1
• BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
• CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
• 238000011887 Necropsy Methods 0.000 description 1
• 102000008730 Nestin Human genes 0.000 description 1
• 108010088225 Nestin Proteins 0.000 description 1
• 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 1
• 102000008763 Neurofilament Proteins Human genes 0.000 description 1
• 108010088373 Neurofilament Proteins Proteins 0.000 description 1
• 208000036365 Normal labour Diseases 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 102100022220 Nuclear envelope integral membrane protein 1 Human genes 0.000 description 1
• 102100038856 Nuclear pore complex-interacting protein family member B3 Human genes 0.000 description 1
• 102100037826 Nucleoporin NDC1 Human genes 0.000 description 1
• 101710093525 Nucleoporin NDC1 Proteins 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 208000003435 Optic Neuritis Diseases 0.000 description 1
• 102100021079 Ornithine decarboxylase Human genes 0.000 description 1
• 101710120430 Ornithine decarboxylase 1 Proteins 0.000 description 1
• 201000009859 Osteochondrosis Diseases 0.000 description 1
• 102000008108 Osteoprotegerin Human genes 0.000 description 1
• 108010035042 Osteoprotegerin Proteins 0.000 description 1
• 102100029879 PCNA-associated factor Human genes 0.000 description 1
• 101150080255 PEP1 gene Proteins 0.000 description 1
• 102100036870 PHD finger protein 19 Human genes 0.000 description 1
• 101710106134 PHD finger protein 19 Proteins 0.000 description 1
• 102000025443 POZ domain binding proteins Human genes 0.000 description 1
• 108091014659 POZ domain binding proteins Proteins 0.000 description 1
• 239000002033 PVDF binder Substances 0.000 description 1
• 208000016222 Pancreatic disease Diseases 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 102100037887 Patched domain-containing protein 4 Human genes 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 208000027086 Pemphigus foliaceus Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 102100034943 Peptidyl-prolyl cis-trans isomerase F, mitochondrial Human genes 0.000 description 1
• 208000018262 Peripheral vascular disease Diseases 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
• 108010004478 Phenylalanine-tRNA Ligase Proteins 0.000 description 1
• 102100029354 Phenylalanine-tRNA ligase, mitochondrial Human genes 0.000 description 1
• 102100022771 Phosphatidylcholine:ceramide cholinephosphotransferase 2 Human genes 0.000 description 1
• 101710145833 Phosphatidylcholine:ceramide cholinephosphotransferase 2 Proteins 0.000 description 1
• 102100036253 Phosphatidylinositol-glycan biosynthesis class W protein Human genes 0.000 description 1
• 102100036629 Phosphoglucomutase-2 Human genes 0.000 description 1
• 101710105359 Phosphoglucomutase-2 Proteins 0.000 description 1
• 108010064785 Phospholipases Proteins 0.000 description 1
• 102000015439 Phospholipases Human genes 0.000 description 1
• 108090000216 Phospholipid Transfer Proteins Proteins 0.000 description 1
• 102000003867 Phospholipid Transfer Proteins Human genes 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 101710193226 Plexin-2 Proteins 0.000 description 1
• 102100034381 Plexin-A2 Human genes 0.000 description 1
• 102000004257 Potassium Channel Human genes 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 208000034943 Primary Sjögren syndrome Diseases 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 102100022407 Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase Human genes 0.000 description 1
• 101710096655 Probable acetoacetate decarboxylase 1 Proteins 0.000 description 1
• 102100024518 Protein cornichon homolog 3 Human genes 0.000 description 1
• 102100036468 Protein diaphanous homolog 3 Human genes 0.000 description 1
• 102100033947 Protein regulator of cytokinesis 1 Human genes 0.000 description 1
• 108050001955 Protein regulator of cytokinesis 1 Proteins 0.000 description 1
• 102100024287 Protein timeless homolog Human genes 0.000 description 1
• 108010003894 Protein-Lysine 6-Oxidase Proteins 0.000 description 1
• 102100026858 Protein-lysine 6-oxidase Human genes 0.000 description 1
• 108700020978 Proto-Oncogene Proteins 0.000 description 1
• 102000052575 Proto-Oncogene Human genes 0.000 description 1
• 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
• 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
• 102100036393 Protocadherin-16 Human genes 0.000 description 1
• 102100029629 Putative trypsin-6 Human genes 0.000 description 1
• 101710193986 Putative trypsin-6 Proteins 0.000 description 1
• 102000001170 RAD18 Human genes 0.000 description 1
• 102100034117 RING finger protein 122 Human genes 0.000 description 1
• 101710089995 RING finger protein 122 Proteins 0.000 description 1
• 102100023750 RNA polymerase II elongation factor ELL2 Human genes 0.000 description 1
• 102000002490 Rad51 Recombinase Human genes 0.000 description 1
• 108010068097 Rad51 Recombinase Proteins 0.000 description 1
• 102000016678 Ran GTPases Human genes 0.000 description 1
• 108050006294 Ran GTPases Proteins 0.000 description 1
• 206010071141 Rasmussen encephalitis Diseases 0.000 description 1
• 208000004160 Rasmussen subacute encephalitis Diseases 0.000 description 1
• 102000001218 Rec A Recombinases Human genes 0.000 description 1
• 108010055016 Rec A Recombinases Proteins 0.000 description 1
• 108010012737 RecQ Helicases Proteins 0.000 description 1
• 102000019196 RecQ Helicases Human genes 0.000 description 1
• 102100038066 Renal cancer differentiation gene 1 protein Human genes 0.000 description 1
• 208000017442 Retinal disease Diseases 0.000 description 1
• 102100039120 Retinoblastoma-like protein 1 Human genes 0.000 description 1
• 206010038923 Retinopathy Diseases 0.000 description 1
• 102100031354 Rho GTPase-activating protein 11A Human genes 0.000 description 1
• 101710129852 Rho GTPase-activating protein 11A Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 102000014400 SH2 domains Human genes 0.000 description 1
• 108050003452 SH2 domains Proteins 0.000 description 1
• 102100024472 STAM-binding protein Human genes 0.000 description 1
• 101710181165 STAM-binding protein Proteins 0.000 description 1
• 108010083379 Sarcoglycans Proteins 0.000 description 1
• 102000006308 Sarcoglycans Human genes 0.000 description 1
• 101100436059 Schizosaccharomyces pombe (strain 972 / ATCC 24843) cia1 gene Proteins 0.000 description 1
• 208000034189 Sclerosis Diseases 0.000 description 1
• 102000009203 Sema domains Human genes 0.000 description 1
• 108050000099 Sema domains Proteins 0.000 description 1
• 102100031400 Serine/threonine-protein kinase Nek7 Human genes 0.000 description 1
• 102100029938 Serine/threonine-protein kinase SMG1 Human genes 0.000 description 1
• 101710085356 Serine/threonine-protein kinase SMG1 Proteins 0.000 description 1
• 102000000277 Shugoshin 2 Human genes 0.000 description 1
• 108050008814 Shugoshin 2 Proteins 0.000 description 1
• 102100023776 Signal peptidase complex subunit 2 Human genes 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 102100027339 Slit homolog 3 protein Human genes 0.000 description 1
• ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 102000005157 Somatostatin Human genes 0.000 description 1
• 108010056088 Somatostatin Proteins 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 108010019965 Spectrin Proteins 0.000 description 1
• 102000005890 Spectrin Human genes 0.000 description 1
• 102100021915 Sperm-associated antigen 5 Human genes 0.000 description 1
• 101710098571 Sperm-associated antigen 5 Proteins 0.000 description 1
• 102100025252 StAR-related lipid transfer protein 13 Human genes 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108010055297 Sterol Esterase Proteins 0.000 description 1
• 102000000019 Sterol Esterase Human genes 0.000 description 1
• 241000272534 Struthio camelus Species 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 102100030701 Synaptic vesicle glycoprotein 2A Human genes 0.000 description 1
• 101710084141 Synaptic vesicle glycoprotein 2A Proteins 0.000 description 1
• 201000009594 Systemic Scleroderma Diseases 0.000 description 1
• 208000018359 Systemic autoimmune disease Diseases 0.000 description 1
• 206010042953 Systemic sclerosis Diseases 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• 102100024813 Targeting protein for Xklp2 Human genes 0.000 description 1
• 208000021945 Tendon injury Diseases 0.000 description 1
• 102100036407 Thioredoxin Human genes 0.000 description 1
• 102000001639 Thioredoxin Reductase 1 Human genes 0.000 description 1
• 108010093836 Thioredoxin Reductase 1 Proteins 0.000 description 1
• 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
• 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
• 108010000499 Thromboplastin Proteins 0.000 description 1
• 102000002262 Thromboplastin Human genes 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 102100034838 Thymidine kinase, cytosolic Human genes 0.000 description 1
• 102000005497 Thymidylate Synthase Human genes 0.000 description 1
• 239000000898 Thymopoietin Substances 0.000 description 1
• 208000024799 Thyroid disease Diseases 0.000 description 1
• AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
• 108050001368 Tight junction protein ZO-2 Proteins 0.000 description 1
• 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 1
• 208000000323 Tourette Syndrome Diseases 0.000 description 1
• 102100028601 Transaldolase Human genes 0.000 description 1
• 101710094436 Transaldolase 1 Proteins 0.000 description 1
• 108010048992 Transcription Factor 4 Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102100023489 Transcription factor 4 Human genes 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• 102000014701 Transketolase Human genes 0.000 description 1
• 108010043652 Transketolase Proteins 0.000 description 1
• 102100034851 Transmembrane protein 106C Human genes 0.000 description 1
• 101710175920 Transmembrane protein 106C Proteins 0.000 description 1
• 102100037029 Transmembrane protein 119 Human genes 0.000 description 1
• 101710170979 Transmembrane protein 119 Proteins 0.000 description 1
• 102100033042 Transmembrane protein 154 Human genes 0.000 description 1
• 101710171132 Transmembrane protein 154 Proteins 0.000 description 1
• 102100036757 Transmembrane protein 62 Human genes 0.000 description 1
• 101710106926 Transmembrane protein 62 Proteins 0.000 description 1
• 206010051956 Trichorhinophalangeal syndrome Diseases 0.000 description 1
• 102000011408 Tripartite Motif Proteins Human genes 0.000 description 1
• 108010023649 Tripartite Motif Proteins Proteins 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 102100036821 Tubulin beta-4B chain Human genes 0.000 description 1
• 102100033470 Tubulointerstitial nephritis antigen Human genes 0.000 description 1
• 101710185398 Tubulointerstitial nephritis antigen Proteins 0.000 description 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
• 102000018472 Type I Keratins Human genes 0.000 description 1
• 108010091525 Type I Keratins Proteins 0.000 description 1
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 101150037257 VPS10 gene Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• 241001416177 Vicugna pacos Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 108010048673 Vitronectin Receptors Proteins 0.000 description 1
• 102100032574 Voltage-dependent L-type calcium channel subunit alpha-1C Human genes 0.000 description 1
• 108700020987 Wnt-1 Proteins 0.000 description 1
• 102000052547 Wnt-1 Human genes 0.000 description 1
• 241000269368 Xenopus laevis Species 0.000 description 1
• 101100163864 Xenopus laevis asf1aa gene Proteins 0.000 description 1
• 102100028431 Zinc finger protein 292 Human genes 0.000 description 1
• 101710147076 Zinc finger protein 292 Proteins 0.000 description 1
• 108700007341 Zonula Occludens-2 Proteins 0.000 description 1
• JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
• AGQFLEFSRLZALV-KQYNXXCUSA-N [9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-3-yl]phosphonic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(N(C=NC2=N)P(O)(O)=O)=C2N=C1 AGQFLEFSRLZALV-KQYNXXCUSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 102000034337 acetylcholine receptors Human genes 0.000 description 1
• 210000001361 achilles tendon Anatomy 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 208000037919 acquired disease Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 108091006088 activator proteins Proteins 0.000 description 1
• 239000000488 activin Substances 0.000 description 1
• 108010023082 activin A Proteins 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 208000024340 acute graft versus host disease Diseases 0.000 description 1
• 230000003044 adaptive effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• QDFHPFSBQFLLSW-KQYNXXCUSA-N adenosine 2'-phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1OP(O)(O)=O QDFHPFSBQFLLSW-KQYNXXCUSA-N 0.000 description 1
• 230000009815 adipogenic differentiation Effects 0.000 description 1
• 230000002293 adipogenic effect Effects 0.000 description 1
• 238000005273 aeration Methods 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 239000002160 alpha blocker Substances 0.000 description 1
• 101150087698 alpha gene Proteins 0.000 description 1
• 108090000183 alpha-2-Antiplasmin Proteins 0.000 description 1
• 102000003801 alpha-2-Antiplasmin Human genes 0.000 description 1
• 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 1
• 210000001691 amnion Anatomy 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
• 238000002266 amputation Methods 0.000 description 1
• 229960004238 anakinra Drugs 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 230000002491 angiogenic effect Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 230000000781 anti-lymphocytic effect Effects 0.000 description 1
• 230000001857 anti-mycotic effect Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000002543 antimycotic Substances 0.000 description 1
• 238000002617 apheresis Methods 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 230000001174 ascending effect Effects 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 208000037896 autoimmune cutaneous disease Diseases 0.000 description 1
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
• 208000037979 autoimmune inflammatory disease Diseases 0.000 description 1
• 201000004339 autoimmune neuropathy Diseases 0.000 description 1
• 229960002170 azathioprine Drugs 0.000 description 1
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 210000001142 back Anatomy 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000012742 biochemical analysis Methods 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 230000002051 biphasic effect Effects 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 239000001045 blue dye Substances 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• 229940053031 botulinum toxin Drugs 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 208000006752 brain edema Diseases 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 208000000594 bullous pemphigoid Diseases 0.000 description 1
• 229940111214 busulfan injection Drugs 0.000 description 1
• 102000014823 calbindin Human genes 0.000 description 1
• 108060001061 calbindin Proteins 0.000 description 1
• 210000000459 calcaneus Anatomy 0.000 description 1
• 229960005084 calcitriol Drugs 0.000 description 1
• GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 239000004068 calcium phosphate ceramic Substances 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 239000002729 catgut Substances 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 229940106189 ceramide Drugs 0.000 description 1
• 150000001783 ceramides Chemical class 0.000 description 1
• 210000001627 cerebral artery Anatomy 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 230000005465 channeling Effects 0.000 description 1
• WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
• 229960003677 chloroquine Drugs 0.000 description 1
• 229960002688 choline salicylate Drugs 0.000 description 1
• 208000012601 choreatic disease Diseases 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 208000037976 chronic inflammation Diseases 0.000 description 1
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 206010009887 colitis Diseases 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 210000001608 connective tissue cell Anatomy 0.000 description 1
• 238000007596 consolidation process Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 229940111134 coxibs Drugs 0.000 description 1
• 201000005637 crescentic glomerulonephritis Diseases 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
• 229960004397 cyclophosphamide Drugs 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 108050004038 cystatin Proteins 0.000 description 1
• 238000007822 cytometric assay Methods 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000005786 degenerative changes Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 210000003074 dental pulp Anatomy 0.000 description 1
• 210000004268 dentin Anatomy 0.000 description 1
• 229960001259 diclofenac Drugs 0.000 description 1
• DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 238000001085 differential centrifugation Methods 0.000 description 1
• HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
• 229960000616 diflunisal Drugs 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 208000032625 disorder of ear Diseases 0.000 description 1
• 108010007093 dispase Proteins 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 210000003027 ear inner Anatomy 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 210000004177 elastic tissue Anatomy 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000008753 endothelial function Effects 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 235000020774 essential nutrients Nutrition 0.000 description 1
• 229960000403 etanercept Drugs 0.000 description 1
• DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
• 229960005293 etodolac Drugs 0.000 description 1
• XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 229940012444 factor xiii Drugs 0.000 description 1
• 210000003195 fascia Anatomy 0.000 description 1
• 229960001419 fenoprofen Drugs 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 231100000562 fetal loss Toxicity 0.000 description 1
• 210000000604 fetal stem cell Anatomy 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 238000010304 firing Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 229960002390 flurbiprofen Drugs 0.000 description 1
• SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 239000000659 freezing mixture Substances 0.000 description 1
• 108010015043 fructosamine-3-kinase Proteins 0.000 description 1
• 238000011990 functional testing Methods 0.000 description 1
• 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 1
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
• 125000002642 gamma-glutamyl group Chemical group 0.000 description 1
• 239000008246 gaseous mixture Substances 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 230000002518 glial effect Effects 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 208000007345 glycogen storage disease Diseases 0.000 description 1
• 201000004502 glycogen storage disease II Diseases 0.000 description 1
• 102000011054 glycogenin Human genes 0.000 description 1
• 108010062764 glycogenin Proteins 0.000 description 1
• 150000002343 gold Chemical class 0.000 description 1
• 230000002710 gonadal effect Effects 0.000 description 1
• 208000024908 graft versus host disease Diseases 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 229960000789 guanidine hydrochloride Drugs 0.000 description 1
• RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
• 210000003780 hair follicle Anatomy 0.000 description 1
• 210000001255 hallux Anatomy 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
• 210000000777 hematopoietic system Anatomy 0.000 description 1
• 208000018706 hematopoietic system disease Diseases 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 238000007489 histopathology method Methods 0.000 description 1
• 239000012510 hollow fiber Substances 0.000 description 1
• 108010027263 homeobox protein HOXA9 Proteins 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 229940099552 hyaluronan Drugs 0.000 description 1
• KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
• 229960003160 hyaluronic acid Drugs 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 1
• 229960004171 hydroxychloroquine Drugs 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 208000009326 ileitis Diseases 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 229960000905 indomethacin Drugs 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 229960000598 infliximab Drugs 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940076264 interleukin-3 Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 229940100994 interleukin-7 Drugs 0.000 description 1
• 201000006334 interstitial nephritis Diseases 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 210000001503 joint Anatomy 0.000 description 1
• 108010011989 karyopherin alpha 2 Proteins 0.000 description 1
• DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
• 229960000991 ketoprofen Drugs 0.000 description 1
• 229960004752 ketorolac Drugs 0.000 description 1
• OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 229940043355 kinase inhibitor Drugs 0.000 description 1
• 108091070195 kinin family Proteins 0.000 description 1
• 210000003127 knee Anatomy 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 238000011031 large-scale manufacturing process Methods 0.000 description 1
• 230000000503 lectinlike effect Effects 0.000 description 1
• 229960000681 leflunomide Drugs 0.000 description 1
• VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
• VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 description 1
• 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000001365 lymphatic vessel Anatomy 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
• 230000017156 mRNA modification Effects 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 229940072082 magnesium salicylate Drugs 0.000 description 1
• 229940091250 magnesium supplement Drugs 0.000 description 1
• 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
• 108090000286 malate dehydrogenase (decarboxylating) Proteins 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 108010082117 matrigel Proteins 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 229940013798 meclofenamate Drugs 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 206010062198 microangiopathy Diseases 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 238000001000 micrograph Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 206010063344 microscopic polyangiitis Diseases 0.000 description 1
• 230000003228 microsomal effect Effects 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000009525 mild injury Effects 0.000 description 1
• 108010071421 milk fat globule Proteins 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 230000002297 mitogenic effect Effects 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 230000036456 mitotic arrest Effects 0.000 description 1
• 230000000394 mitotic effect Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000037230 mobility Effects 0.000 description 1
• 230000009526 moderate injury Effects 0.000 description 1
• 238000007479 molecular analysis Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 230000004899 motility Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 230000003551 muscarinic effect Effects 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 201000006938 muscular dystrophy Diseases 0.000 description 1
• 230000036473 myasthenia Effects 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• AEMBWNDIEFEPTH-UHFFFAOYSA-N n-tert-butyl-n-ethylnitrous amide Chemical compound CCN(N=O)C(C)(C)C AEMBWNDIEFEPTH-UHFFFAOYSA-N 0.000 description 1
• 229960004270 nabumetone Drugs 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 229960002009 naproxen Drugs 0.000 description 1
• CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 230000002956 necrotizing effect Effects 0.000 description 1
• 230000006213 negative regulation of lymphocyte proliferation Effects 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 210000005055 nestin Anatomy 0.000 description 1
• 210000001178 neural stem cell Anatomy 0.000 description 1
• 210000002241 neurite Anatomy 0.000 description 1
• 230000009449 neurobehavioral function Effects 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 210000000461 neuroepithelial cell Anatomy 0.000 description 1
• 210000005044 neurofilament Anatomy 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 230000004031 neuronal differentiation Effects 0.000 description 1
• 230000000324 neuroprotective effect Effects 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 210000004967 non-hematopoietic stem cell Anatomy 0.000 description 1
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
• 231100000065 noncytotoxic Toxicity 0.000 description 1
• 230000002020 noncytotoxic effect Effects 0.000 description 1
• 210000000633 nuclear envelope Anatomy 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 125000003729 nucleotide group Chemical group 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 230000000414 obstructive effect Effects 0.000 description 1
• 210000001706 olfactory mucosa Anatomy 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 150000002892 organic cations Chemical class 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000009818 osteogenic differentiation Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 229960005489 paracetamol Drugs 0.000 description 1
• 230000001936 parietal effect Effects 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 201000001976 pemphigus vulgaris Diseases 0.000 description 1
• 229960001639 penicillamine Drugs 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000002379 periodontal ligament Anatomy 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000000858 peroxisomal effect Effects 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 229940127557 pharmaceutical product Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
• 229960002895 phenylbutazone Drugs 0.000 description 1
• VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
• 229960002702 piroxicam Drugs 0.000 description 1
• QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 210000005152 placental membrane Anatomy 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 239000002985 plastic film Substances 0.000 description 1
• 229920006255 plastic film Polymers 0.000 description 1
• 101150105924 plx-2 gene Proteins 0.000 description 1
• 229920000083 poly(allylamine) Polymers 0.000 description 1
• 229920002492 poly(sulfone) Polymers 0.000 description 1
• 229920001281 polyalkylene Polymers 0.000 description 1
• 229920000447 polyanionic polymer Polymers 0.000 description 1
• 229920000867 polyelectrolyte Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000002980 postoperative effect Effects 0.000 description 1
• 108020001213 potassium channel Proteins 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000000955 prescription drug Substances 0.000 description 1
• 238000004886 process control Methods 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 238000012514 protein characterization Methods 0.000 description 1
• 230000006916 protein interaction Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 238000000575 proteomic method Methods 0.000 description 1
• 101710134316 rRNA 2'-O-methyltransferase fibrillarin Proteins 0.000 description 1
• 101150119028 rbn gene Proteins 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 229940116176 remicade Drugs 0.000 description 1
• 125000006853 reporter group Chemical group 0.000 description 1
• 230000033458 reproduction Effects 0.000 description 1
• 230000001850 reproductive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 210000001995 reticulocyte Anatomy 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 201000011574 retinitis pigmentosa 2 Diseases 0.000 description 1
• 229930002330 retinoic acid Natural products 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 108010004650 rho GTPase-activating protein Proteins 0.000 description 1
• 230000000630 rising effect Effects 0.000 description 1
• 101150099264 rnz gene Proteins 0.000 description 1
• 229960000953 salsalate Drugs 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 210000004761 scalp Anatomy 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• 230000009758 senescence Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000009528 severe injury Effects 0.000 description 1
• 208000037974 severe injury Diseases 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 230000003584 silencer Effects 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 229940083542 sodium Drugs 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 229960004025 sodium salicylate Drugs 0.000 description 1
• YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
• 229960000553 somatostatin Drugs 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 229960001940 sulfasalazine Drugs 0.000 description 1
• NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
• NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
• 229960000894 sulindac Drugs 0.000 description 1
• MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000011477 surgical intervention Methods 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 102000003137 synaptotagmin Human genes 0.000 description 1
• 108060008004 synaptotagmin Proteins 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229940094937 thioredoxin Drugs 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 208000021510 thyroid gland disease Diseases 0.000 description 1
• 239000005495 thyroid hormone Substances 0.000 description 1
• 229940036555 thyroid hormone Drugs 0.000 description 1
• 206010043778 thyroiditis Diseases 0.000 description 1
• 239000003104 tissue culture media Substances 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 229960001017 tolmetin Drugs 0.000 description 1
• UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 239000003440 toxic substance Substances 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 229960004380 tramadol Drugs 0.000 description 1
• TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• 229960001727 tretinoin Drugs 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 229940078499 tricalcium phosphate Drugs 0.000 description 1
• 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
• 230000001573 trophoblastic effect Effects 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 238000007631 vascular surgery Methods 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 230000002861 ventricular Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000009278 visceral effect Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 102000009310 vitamin D receptors Human genes 0.000 description 1
• 108050000156 vitamin D receptors Proteins 0.000 description 1
• 208000006542 von Hippel-Lindau disease Diseases 0.000 description 1
• 239000003643 water by type Substances 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 239000013585 weight reducing agent Substances 0.000 description 1
• 210000001325 yolk sac Anatomy 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1